Participants speak about their involvement in the Walter Reed Army Institute of Research's (WRAIR) phase I clinical trial for WRAIR's spike ferritin nanoparticle (SpFN) vaccine at the WRAIR Clinical Trials Center. Built on a ferritin platform, the vaccine offers a flexible approach to targeting multiple variants of the virus that causes COVID-19 and potentially other coronaviruses as well. (Army video by Mike Walters/ Released)
| Date Taken: | 04.07.2021 |
| Date Posted: | 07.02.2021 19:02 |
| Category: | Package |
| Video ID: | 805427 |
| VIRIN: | 210407-A-PR201-017 |
| Filename: | DOD_108429937 |
| Length: | 00:01:30 |
| Location: | SILVER SPRING, MARYLAND, US |
| Downloads: | 3 |
| High-Res. Downloads: | 3 |
This work, WRAIR begins phase I trial for it's Coronavirus vaccine candidate, by Mike Walters, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
